A data-driven screen of 16 extract combinations derived from broccoli, licorice, passionflower, and lemon balm identified an optimized three-component blend (Blend 2) that simultaneously restored mitochondrial respiration, ATP production, and citrate synthase activity under DNA damage conditions. The mechanism operates through SIRT1-AMPK-PGC-1α pathway activation and enhanced mitophagy, while also suppressing the senescence-associated secretory phenotype (SASP) via NF-κB inhibition and selectively clearing senescent cells through Bax/caspase-mediated apoptosis.
The dual senotherapeutic action here — both senostatic (SASP suppression) and senolytic (senescent cell elimination) — is what makes this finding noteworthy. Most natural compounds achieve one or the other; hitting both simultaneously addresses a genuine therapeutic gap. The SIRT1-AMPK-PGC-1α axis is among the most validated longevity pathways in aging biology, appearing in caloric restriction, exercise, and NAD+ research, so anchoring a food-derived blend to this mechanism adds credibility.
Critical caveats apply, however. This appears to be entirely cell-based work — no animal models, no human cohorts. In vitro senolytic and mitochondrial findings frequently fail to translate given bioavailability challenges; licorice glycyrrhizin and broccoli sulforaphane, for instance, have complex and dose-dependent pharmacokinetics in vivo. The data-driven screening methodology is methodologically interesting but screens 16 combinations — a modest combinatorial space. Considered incremental-to-promising: strong mechanistic rationale, but preclinical validation in living organisms remains essential before any practical longevity application can be claimed.
